StockData
Odyssey Therapeutics, Inc. logo

Odyssey Therapeutics, Inc. (ODTX) stock

ODTXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026
$18.98−0.39 (-2.01%)

Close on Nov 18, 2026Market cap $912.15MP/E –Yield –

Odyssey Therapeutics net income

Net income is the profit left for shareholders after every expense, interest and tax.

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$52.79M–
Q1 FY2026Mar 31, 2026-$38.26M–
Q2 FY2025Jun 30, 2025-$41.24M–
Q1 FY2025Mar 31, 2025-$38.44M–

More Odyssey Therapeutics figures

See a number that looks wrong?